Research News

Liver cancer remains one of the worlds most lethal cancers, ranking as the third leading cause of cancer-related deaths. Although surgical advances have improved safety, recurrence after hepatectomy continues to be a major challenge.

Since ancient times, it was thought that painful stomach ulcers were caused by eating spicy foods or having an unhealthy diet. But since then, researchers have found that Helicobacter pylori a common bacterium found in over 60% of the world’s population—was the real culprit behind most stomach ulcers and a high risk for stomach cancer.

HTLV‑1 – the first human retrovirus to be identified, in 1977 – affects at least 5-10 million people globally. It is concentrated in western and central Africa, Latin America, and the Western Pacific Region.

Targeted drug delivery is a powerful and promising area of medicine. Therapies that pinpoint the exact areas of the body where they’re needed and nowhere they’re not can reduce the medicine dosage and avoid potentially harmful “off target” effects elsewhere in the body.

An international team of scientists has generated a new ring-shaped protein nanomaterial capable of strongly binding to and neutralising the SARS-CoV2 virus.

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations, finds a major international trial led by UCL researchers.

Scientists at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S., and a leading research center for diabetes and other life-threatening illnesses, have uncovered a gene called SMOC1 that plays a surprising role in the development of type 2 diabetes (T2D) by converting pancreatic cells that normally produce insulin into those that increase blood sugar.

A new study has found that a simple kitchen ingredient — vinegar — can become a powerful germ killer when mixed with special microscopic particles. Scientists have discovered that this new combination could help fight dangerous bacteria that no longer respond to regular antibiotics.